OptiCept Q1'24: Clear steps towards building large scale business
OptiCept’s Q1 figures were below our estimates. However, the Company's investment story is based on long-term commercial success and the company has taken important operational steps towards reaching this during the first half of 2024. The recently announced FPS order was a clear breakthrough for the company, which not only validates the technology but also shows signs of clear end consumer demand. Thus, we have revised our estimates upwards. In addition, the company has secured financing through debt, at favorable terms, and warrants that we assume will be fully redeemed. As a result, we believe that the overall risks associated with financing have come down. However, in our view, given the uncertainty regarding whether the company will continue to receive larger order on a regular basis and to what profitability, the stock is already sufficiently priced in for high revenue growth (2025e EV/S: 3.2x).
Login required
This content is only available for logged in users
OptiCept Technologies
OptiCept Technologies is a provider of the food and plant industry with technological solutions that are used to increase the sustainability of various raw materials. The company works with biological processes that provide increased extraction from the raw material, extended shelf life reduced waste, and retained taste, aroma, color, the nutritional content of the end product. The company has a patented technology within PEF (pulsed electric field) and VI (Vacuum Infusion). The company sells its products on a global level and is headquartered in Lund.
Read more on company pageKey Estimate Figures04.06.
2023 | 24e | 25e | |
---|---|---|---|
Revenue | 9.1 | 47.3 | 89.0 |
growth-% | -12.90 % | 417.64 % | 88.00 % |
EBIT (adj.) | -73.6 | -38.7 | -17.8 |
EBIT-% (adj.) | -804.81 % | -81.85 % | -19.97 % |
EPS (adj.) | -2.00 | -0.91 | -0.38 |
Dividend | 0.00 | 0.00 | 0.00 |
Dividend % | |||
P/E (adj.) | - | - | - |
EV/EBITDA | - | - | 92.77 |